The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Open accessAbstract
Recent estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008. The number of patients with cancer diagnosed between 2004 and 2008 who were still alive at the end of 2008 in the adult population is described by world region, country and the human development index. The 5‐year global cancer prevalence is estimated to be 28.8 million in 2008. Close to half of the prevalence burden is in areas of very high human development that comprise only one‐sixth of the world's population. Breast cancer continues to be the most prevalent cancer in the vast majority of countries globally; cervix cancer is the most prevalent cancer in much of Sub‐Saharan Africa and Southern Asia and prostate cancer dominates in North America, Oceania and Northern and Western Europe. Stomach cancer is the most prevalent cancer in Eastern Asia (including China); oral cancer ranks as the most prevalent cancer in Indian men and Kaposi sarcoma has the highest 5‐year prevalence among men in 11 countries in Sub‐Saharan Africa. The methods used to estimate point prevalence appears to give reasonable results at the global level. The figures highlight the need for long‐term care targeted at managing patients with certain very frequently diagnosed cancer forms. To be of greater relevance to cancer planning, the estimation of other time‐based measures of global prevalence is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Self-citationGlobal Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Self-citationThe United Nations Development Programme
Oestreich, J. E. (2017) · Development and Human Rights · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,894
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Self-citationBerrino, F., De Angelis, R., Sant, M., Rosso, S., Lasota, M. B., Coebergh, J. W., & Santaquilani, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70245-0 · Cited by 807
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
Pisani, P., Bray, F., & Parkin, D. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.1571 · Cited by 730
Self-citationCancer survival in Africa, Asia, and Central America: a population-based study
Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K. S., Chen, J. G., Law, S. C., Ahn, Y.-O., Xiang, Y. B., Yeole, B. B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70335-3 · Cited by 616
Soerjomataram, I., Lortet-Tieulent, J., Parkin, D. M., Ferlay, J., Mathers, C., Forman, D., & Bray, F. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60919-2 · Cited by 598
Self-citationNORDCAN – a Nordic tool for cancer information, planning, quality control and research
Engholm, G., Ferlay, J., Christensen, N., Bray, F., Gjerstorff, M. L., Klint, Å., Køtlum, J. E., Ólafsdóttir, E., Pukkala, E., & Storm, H. H. (2010) · Acta Oncologica · doi:10.3109/02841861003782017 · Cited by 537
Self-citationParkin, D. M., Bray, F. I., & Devesa, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00739-6 · Cited by 479
Self-citationMultiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship
Mariotto, A. B., Rowland, J. H., Ries, L. A. G., Scoppa, S., & Feuer, E. J. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0782 · Cited by 283
Cancer prevalence in the United Kingdom: estimates for 2008
Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M., & Møller, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605148 · Cited by 244
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
Jung, K.-W., Park, S., Kong, H.-J., Won, Y.-J., Lee, J. Y., Park, E.-C., & Lee, J.-S. (2011) · Cancer Research and Treatment · doi:10.4143/crt.2011.43.1.1 · Cited by 231
Estimation and projections of cancer prevalence from cancer registry data
Verdecchia, A., Angelis, G. D., & Capocaccia, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1304 · Cited by 120
Merrill, R. M., Capocaccia, R., Feuer, E. J., & Mariotto, A. B. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.197 · Cited by 118
Measuring cancer prevalence in Europe: the EUROPREVAL Project
Capocaccia, R., Colonna, M., Corazziari, I., Angelis, R. D., Francisci, S., Micheli, A., & Mugno, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf152 · Cited by 105
Soerjomataram, I., Lortet‐Tieulent, J., Ferlay, J., Forman, D., Mathers, C. D., Parkin, D. M., & Bray, F. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-125 · Cited by 92
Self-citationCancer survival in Africa, Asia, the Caribbean and Central America: database and attributes.
Swaminathan, R., Lucas, E., & Sankaranarayanan, R. (2011) · PubMed · Cited by 83
Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured?
Brenner, H., & Hakulinen, T. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.067 · Cited by 83
Breast cancer survivors in the United States
Angelis, R. D., Tavilla, A., Verdecchia, A., Scoppa, S., Hachey, M., Feuer, E. J., & Mariotto, A. B. (2009) · Cancer · doi:10.1002/cncr.24217 · Cited by 71
How important are estimates of cancer prevalence?
Giles, G. G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf204 · Cited by 25
Estimating the prevalence of breast cancer using a disease model: data problems and trends
Kruijshaar, M. E., Barendregt, J. J., & van de Poll-Franse, L. V. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-5 · Cited by 21
Research works printed but not linked: 9
- 10.1016/j.ejca.2007.10.022 · doi:10.1016/j.ejca.2007.10.022
- AIRTUM Working Group. Italian cancer figures, report 2010: cancer prevalence in Italy, 2010, Patients living with cancer, long‐term survivors and cured patients, Epidemiol Prev, 1
- 10.1093/jjco/hym156 · doi:10.1093/jjco/hym156
- 10.1007/s10552-011-9749-0 · doi:10.1007/s10552-011-9749-0
- Louchini R, 2006, Trends in cancer prevalence in Quebec, Chronic Dis Can, 27, 110
- 10.1016/S0959-8049(00)00358-0 · doi:10.1016/s0959-8049(00)00358-0
- 10.1200/JCO.2005.05.127 · doi:10.1200/jco.2005.05.127
- Soerjomataram I, Disability‐adjusted life years: country‐specific estimates for 27 cancers in 12 world regions, The Lancet
- 10.1002/cncr.11631 · doi:10.1002/cncr.11631
Cited by
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Self-citationLee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
Metadata
- Authors
- Bray, F., Ren, J., Masuyer, E., & Ferlay, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2012-07-26
- Volume
- 132
- Issue
- 5
- Pages
- 1133-1145
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2089569798
- Cited by
- 1,891
- References
- 24
- FWCI
- 79.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.